The legislation will make it easier for qualified patients to register for the state’s medical cannabis access program and for physicians to participate in it.
Archives: News Releases
Since 1992, every Thursday and when breaking news warrants, NORML | The NORML Foundation have been issuing weekly press releases for marijuana law supporters and the media.
NORML’s News Releases archives goes back to 1996 and serves as a valuable tool to alert citizens about cannabis-related news and legislation as well as a research tool for reviewing a chronology of marijuana law reform.
Participants reported statistically significant improvements in their quality of life and employment status following cannabis treatment.
“[T]he ability of whole-plant cannabis extracts to reduce opioid reward and drug seeking behavior appears quite robust and of great clinical utility,” authors concluded.
Investigators concluded, “Medicinal cannabis, in a balanced formulation, may address a variety of conditions and can be safely prescribed by a medical doctor.”
“Overall, there is no clear evidence that [legalization] had any effect on rates of ED visits and hospitalizations for either motor vehicle or pedestrian/cyclist injury,” authors determined.
The pending legislation raises the amount of THC-infused products patients can legally possess.
NORML opposes HB 1053 because it unduly interferes with doctor/patient relations.
Clinicians ordered drug tests to be performed on Black newborns at nearly four times the rate of other children, the study found.